Author:
Cizman Borut,Smith Helen T.,Camejo Rodrigo Refoios,Casillas Linda,Dhillon Harjeet,Mu Fan,Wu Eric,Xie Jipan,Zuckerman Peter,Coyne Daniel
Subject
Nephrology,Internal Medicine
Reference24 articles.
1. Mechanisms of anemia in CKD;Babitt;J Am Soc Nephrol,2012
2. Normalization of hemoglobin level in patients with chronic kidney disease and anemia;Drueke;N Engl J Med,2006
3. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease;Pfeffer;N Engl J Med,2009
4. Correction of anemia with epoetin alfa in chronic kidney disease;Singh;N Engl J Med,2006
5. FDA. FDA Drug Safety Communication: modified dosing recommendations to improve the safety of erythropoiesis-stimulating agents (ESAs) in chronic kidney disease, https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-modified-dosing-recommendations-improve-safe-use-erythropoiesis. 2011. Accessed December 11, 2019.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献